313 related articles for article (PubMed ID: 7239059)
1. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
[No Abstract] [Full Text] [Related]
2. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
[No Abstract] [Full Text] [Related]
3. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.
Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M
Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306
[TBL] [Abstract][Full Text] [Related]
4. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
5. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
Dávid K; Halmy L
Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
[TBL] [Abstract][Full Text] [Related]
6. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
Malacco E; Iacono G; Risso F
Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
[No Abstract] [Full Text] [Related]
9. [Incidence of HAV and HBc antibodies in patients with chronic hepatitis].
Tanno H; Fay O; Roncoroni M; Galimberti B; Palazzi J
Acta Gastroenterol Latinoam; 1980; 10(2):105-11. PubMed ID: 7211130
[TBL] [Abstract][Full Text] [Related]
10. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
[TBL] [Abstract][Full Text] [Related]
11. [HBsAg and anti-HBs in liver diseases, blood donors and hospital personnel].
Schlicht I; Gadow J; Wolter G; Ortmans H; Jorno L; Gentz D
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():568-72. PubMed ID: 612034
[No Abstract] [Full Text] [Related]
12. [Antibodies against e-antigen in patients with HBsAg-positive liver diseases].
Thamer G; Gmelin K; Kommerell B
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():557-8. PubMed ID: 612030
[No Abstract] [Full Text] [Related]
13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
14. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
Dávid K; Halmy L
Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
[No Abstract] [Full Text] [Related]
15. [HB virus antigens in the liver during chronic hepatitis in children].
Alvarez F; Bernard O; Alagille D
Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():767-70. PubMed ID: 6762178
[TBL] [Abstract][Full Text] [Related]
16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
17. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies].
Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R
Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
20. [Localization of HBsAg and HBcAg by peroxidase-labeled antibody].
Hong SF
Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):352-4. PubMed ID: 2994857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
